Alan Cutler, MD
Gastroenterology · Farmington Hills, MINPI 1366425787
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $46,525 of the $70,136 with a category attached, or 66.3%. 43 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 39.0% of the total. Reporting peaked in 2024 at $25,151 and has fallen 85.0% since, to $3,767 in 2025. Among gastroenterology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 973 payments — averaging $72.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$27K
- Phathom Pharmaceuticals, Inc.$22K
- AbbVie$4K
- Redhill Biopharma Inc.$3K
- Johnson & Johnson$2K
- Bristol Myers Squibb$2K
- plus $10K from 37 others
Across 49 payments — averaging $7521.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$201K
- Takeda Pharmaceuticals U.S.A., Inc.$61K
- Bristol Myers Squibb$56K
- Pfizer$29K
- Janssen Research & Development, LLC$12K
- Celltrion, Inc.$10K
What the payments were for
- Consulting fees$3,3655%
- Speaking & faculty fees$46,52566%
- Travel & lodging$2,1403%
- Food & beverage$17,93626%
- Education$1370%
- Gifts$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$70,136 in reported general payments places this provider in the 95th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LinzessLinaclotide | 163 | $132,740 |
| Humira(Cf) PenAdalimumab | 13 | $85,267 |
| Mesalamine | 57 | $32,947 |
| ZenpepLipase/Protease/Amylase | 20 | $31,421 |
| CreonLipase/Protease/Amylase | 14 | $28,924 |
| TrulancePlecanatide | 16 | $15,017 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 140 | $10,099 |
| Mesalamine ErMesalamine | 31 | $9,370 |
| MovantikNaloxegol Oxalate | 13 | $7,752 |
| Omeprazole | 368 | $5,937 |
| Cholestyramine LightCholestyramine | 71 | $4,951 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 159 | $4,067 |
| Budesonide DrBudesonide | 40 | $4,015 |
| Pantoprazole Sodium | 211 | $3,862 |
| Lubiprostone | 27 | $3,848 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess, Creon | $4,053 | $161,664177 claims |
| Aimmune Therapeutics, Inc.Zenpep | $201 | $31,42120 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCTrulance | $787 | $15,01716 claims |
| Redhill Biopharma Inc.Movantik | $2,790 | $7,75213 claims |
| SandozLansoprazole | $13 | $21913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 497 gastroenterology providers in Michigan.
Other gastroenterology in Farmington Hills
- Phillip GoldmeierFarmington Hills$21K
- Michael RaphaelFarmington Hills$21K
- Kimberly BrownDetroit$733K
- Dilip MoonkaDetroit$611K
- Philip SchoenfeldAnn Arbor$539K
- Michelle Muza-MoonsAnn Arbor$481K
- Partha NandiTroy$377K
- Bradford WhitmerSaint Clair Shores$206K
- Mohammed BarawiSt Clair Shores$193K
- Stuart GordonDetroit$178K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.